Last reviewed · How we verify
GEC255 tablets
At a glance
| Generic name | GEC255 tablets |
|---|---|
| Sponsor | GenEros Biopharma Hangzhou Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GEC255 tablets CI brief — competitive landscape report
- GEC255 tablets updates RSS · CI watch RSS
- GenEros Biopharma Hangzhou Ltd portfolio CI